These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1300 related items for PubMed ID: 16053011
1. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. Portolés J, López-Gómez JM, Aljama P. Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011 [Abstract] [Full Text] [Related]
2. Anemia management and treatment response in patients on hemodialysis: the MAR study. Portolés J, López-Gómez JM, Aljama P. J Nephrol; 2006; 19(3):352-60. PubMed ID: 16874697 [Abstract] [Full Text] [Related]
3. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Portolés J, López-Gómez JM, Aljama P. Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492 [Abstract] [Full Text] [Related]
4. [Hypertension in hemodialysis patients in Andalucia]. García Cortés MJ, Ceballos M, Grupo de tabajo sobre Calidad de la Hemodiálisis en Andalucía. Nefrologia; 2004 Feb; 24(2):149-57. PubMed ID: 15219090 [Abstract] [Full Text] [Related]
5. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Sit D, Kadiroglu AK, Yilmaz ME, Kara IH, Isikoglu B. Ren Fail; 2005 Feb; 27(4):403-7. PubMed ID: 16060127 [Abstract] [Full Text] [Related]
6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803 [Abstract] [Full Text] [Related]
7. [Predictors of early death during dialysis]. Caravaca F, Arrobas M, Pizarro JL, Cancho B, Cubero JJ, Espárrago JF, García MC, Sánchez-Casado E. Nefrologia; 2001 Jun 13; 21(3):274-82. PubMed ID: 11471308 [Abstract] [Full Text] [Related]
8. The prevalence of anemia in patients with chronic kidney disease. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M. Curr Med Res Opin; 2004 Sep 13; 20(9):1501-10. PubMed ID: 15383200 [Abstract] [Full Text] [Related]
9. [Occult chronic kidney disease (OCKD), and cardiovascular risk factors. Epidemiologic study]. Otero A, Abelleira A, Gayoso P. Nefrologia; 2005 Sep 13; 25(3):275-87. PubMed ID: 16053009 [Abstract] [Full Text] [Related]
10. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT. Nephrol Dial Transplant; 2006 Sep 13; 21(9):2513-20. PubMed ID: 16799173 [Abstract] [Full Text] [Related]
11. The challenge of cardiovascular risk factors in end-stage renal disease. Covic A, Gusbeth-Tatomir P, Goldsmith DJ. J Nephrol; 2003 Sep 13; 16(4):476-86. PubMed ID: 14696749 [Abstract] [Full Text] [Related]
13. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease. Portolés J, Castelao AM, Gorriz JL, Tato AM, de Alvaro F. Ren Fail; 2009 Sep 13; 31(10):869-75. PubMed ID: 20030520 [Abstract] [Full Text] [Related]
14. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study]. Poch E, Martinez X, Rodrigo JA, Tovar JL, Investigadores del Estudio PRESIDIAL de la Sociedad Catalana de Nefrología. Nefrologia; 2006 Sep 13; 26(5):564-72. PubMed ID: 17117899 [Abstract] [Full Text] [Related]
15. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients. Pernod G, Bosson JL, Golshayan D, Barro C, Alloatti S, Turc-Baron C, Quarello F, Jeantet A, Von Albertini B, Forêt M, Lauren G, Cordonnier D, Piccoli G, Wauters JP, Diamant Alpin Collaborative Dialysis Study Group. J Nephrol; 2004 Sep 13; 17(1):66-75. PubMed ID: 15151261 [Abstract] [Full Text] [Related]
16. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). Martínez-Castelao A, Gòrriz JL, Garcia-López F, López-Revuelta K, De Alvaro F, Cruzado JM, Spanish CALVIDIA Study Group. J Nephrol; 2004 Sep 13; 17(4):544-51. PubMed ID: 15372417 [Abstract] [Full Text] [Related]
17. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, Clase CM. Am J Kidney Dis; 2005 Nov 13; 46(5):845-55. PubMed ID: 16253724 [Abstract] [Full Text] [Related]
18. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study. Bellomo G, Lippi G, Saronio P, Reboldi G, Verdura C, Timio F, Timio M. J Nephrol; 2003 Nov 13; 16(2):245-51. PubMed ID: 12768072 [Abstract] [Full Text] [Related]
19. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease]. Ravera M, Paoletti E. Ital Heart J Suppl; 2004 Jun 13; 5(6):436-44. PubMed ID: 15471148 [Abstract] [Full Text] [Related]
20. [Renal insufficiency is an important cardiovascular risk factor]. Pérez Flores I, Luño J. Nefrologia; 2002 Jun 13; 22(4):306-9. PubMed ID: 12369120 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]